Clinical Trial Detail

NCT ID NCT03400254
Title A Phase Ib/II Trial of Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER") (GLACIER)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

breast cancer

Therapies

Gedatolisib + Hydroxychloroquine

Hydroxychloroquine

Age Groups: adult senior

No variant requirements are available.